NBIX
Neurocrine Biosciences, Inc. · Healthcare
Director Stephen A Sherwin sold $1.1M of Neurocrine Biosciences, Inc.
Sold$1,116,378
$74.43Price
15,000Shares
−37%Stake
What NBIX did after the filing
- The stock from Wed, Jan 26 close, $75.51
- +20.4%
- S&P 500, same days
- −1.8%
Measured over 30 trading days, to the Mar 10 close.
Traded Mon, Jan 24. Filed Wed, Jan 26, 12:52 PM ET, during the session. Returns use the Jan 26 close and the Mar 10 close. Not investment advice.